PT Indofarma Tbk, together with its subsidiaries, manufactures and sells pharmaceutical products in Indonesia and internationally. The company operates through medicine, Medical devices and Others, and Engineering Pharmaceuticals. It engages in marketing, trading and distribution of medicine and medical devices; and clinical lab. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is based in Bekasi, Indonesia. The company operates as a subsidiary of PT Bio Farma.
Frequently asked questions
What sector does Indofarma Tbk (INAF) operate in?
Indofarma Tbk belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Indofarma Tbk (INAF) current stock price?
As of the latest data, Indofarma Tbk stock price is IDR 126, with a previous close of IDR 126.
What is Indofarma Tbk (INAF) current market capitalization?
Indofarma Tbk market cap is approximately 390.51 billion.
What is Indofarma Tbk (INAF) Earnings Per Share (EPS)?
The trailing EPS is -IDR 227.
What is Indofarma Tbk (INAF) EBITDA?
Indofarma Tbk EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.48 billion.
Does Indofarma Tbk (INAF) pay dividends?
No. Indofarma Tbk does not pay a dividend.
What is Indofarma Tbk (INAF) beta (volatility) score?
Indofarma Tbk has a beta of 0.268, indicating lower volatility than the overall market.